ELI LILLY & Co
Close on Nov 3, 2026Market cap $1.33TP/E 45.7Yield 0.44%
Eli Lilly Forteo (teriparatide) by Year
Forteo (teriparatide) — Worldwide revenue ($M) [legacy separate disclosure] ($M)
Eli Lilly Forteo (teriparatide): $533M in FY2023, down 13.0% from a year earlier. That is the lowest of the 8 years on record here. No newer figure appears in the documents we track.
Where the FY2023 figure comes from
“|| Forteo ® | 335.5 | 197.7 | 533.2 | 613.1 | (13)”
Source: Form 10-K FY2023 (filed 2024-02-21) ↗
Reported in Form 10-Q / 10-K Note 2 & MD&A (legacy separate product disclosure prior to FY2025 reorganization).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Forteo (teriparatide) — Worldwide revenue ($M) [legacy separate disclosure] ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2023 | Dec 31, 2023 | 533 | -13.0% | Form 10-K FY2023 (filed 2024-02-21) ↗ |
| FY2022 | Dec 31, 2022 | 613 | -23.5% | Form 10-K FY2022 (filed 2023-02-22) ↗ |
| FY2021 | Dec 31, 2021 | 802 | -23.4% | Form 10-K FY2021 (filed 2022-02-23) ↗ |
| FY2020 | Dec 31, 2020 | 1,046 | -33.6% | Form 10-K FY2020 (filed 2021-02-17) ↗ |
| FY2019 | Dec 31, 2019 | 1,576 | -9.9% | Form 10-K FY2019 (filed 2020-02-19) ↗ |
| FY2018 | Dec 31, 2018 | 1,749 | 0.0% | Form 10-K FY2018 (filed 2019-02-19) ↗ |
| FY2017 | Dec 31, 2017 | 1,749 | +16.6% | Form 10-K (filed 2018-02-20) ↗ |
| FY2016 | Dec 31, 2016 | 1,500 | – | Form 10-K (filed 2018-02-20) ↗ |
Breakdown
What makes up forteo (teriparatide)
Cite this data
StockData. (2026). Eli Lilly Forteo (teriparatide) ($M), annual FY2016–FY2023 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/med-forteo-ww
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.
See a number that looks wrong?